All Medical University of Vienna articles
-
NewsPost-COVID syndrome: new insights into connection between gut health and fatigue
A new study shows that post-COVID syndrome patients have altered inflammatory markers and a disturbed intestinal barrier, which could contribute to the development of post-viral fatigue.
-
NewsOrganoids reveal the secrets of bat immunity
Researchers successfully infected both bat organoids and human airway organoids with the Marburg virus. Compared to the human models, bat organoids exhibited a significantly higher baseline antiviral immune activity even before infection.
-
NewsNew therapeutic approach for severe COVID-19
A new clinical study shows that an inhibitor of Fas ligand, also called CD95 ligand, led to a faster recovery of COVID-19 patients and reduced mortality.
-
NewsSARS-CoV-2 ‘steals’ our proteins to protect itself from the immune system
Researchers at the Medical University of Vienna and the Medical University of Innsbruck discovered that SARS-CoV-2 hijacks three important host proteins that dampen the activity of the complement system, a key component of early antiviral immunity. This significantly impairs viral clearance which may affect the course of ...
-
NewsTwo types of polymicrobial infections in chronic lung diseases
Chronic lung diseases are often accelerated and exacerbated by polymicrobial infections. An international study team led by MedUni Vienna has identified two types of these so-called dysbioses in cystic fibrosis. They display distinct ecology and are also likely to respond differently to treatment. The study was published in the journal ...
-
NewsVaccine boosts innate immunity in people with dormant immune cells
Epigenetic cell states predict whether or not an individual profits from the “wake-up call” to the innate immune system that is provided by the BCG vaccine.
-
NewsMultiple sclerosis: Possible basis for vaccine researched
Researchers have shown that the risk of MS is particularly high in people with a combination of certain host factors and variants of the Epstein-Barr virus (EBV).
-
NewsViruses discovered as new therapy option for atopic dermatitis
Researchers have discovered a new approach to atopic dermatitis - bacteriophages, which colonize the skin as viral components of the microbiome and can drive the development of innovative atopic dermatitis therapies.